EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 1,733 shares, a decrease of 84.5% from the February 12th total of 11,183 shares. Based on an average daily trading volume, of 371,108 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 371,108 shares, the short-interest ratio is currently 0.0 days.
Analyst Ratings Changes
Several analysts have recently commented on the stock. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday, January 15th. UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Finally, Zacks Research downgraded EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on ESLOY
EssilorLuxottica Stock Down 0.2%
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Stories
- Five stocks we like better than EssilorLuxottica
- Goldman’s Crash Warning
- “I just bought 10,000 shares of a $5 stock…”
- J.P. Morgan is betting on this coin
- Have $500? Invest in Elon’s AI Masterplan
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
